Application Receipt/Submission Date(s): August 9, 2006; December 9, 2006;
April 9, 2007; August 9, 2007; December 9, 2007; April 9, 2008.

The goal of this funding opportunity announcement (FOA) is to fund applications focused on the following areas of research: 1) phase I or II clinical trials of novel imaging-agents to ensure their safety and efficacy so that further evaluations of the clinical potentials of these agents can proceed; 2) feasibility studies in image-guided intervention, to establish treatment parameters and early therapeutic efficacy for these methods; and/or 3) clinical feasibility or "proof-of-principle" studies or clinical trials to demonstrate potential efficacy of promising discoveries in imaging or image-guided therapy methodologies or technologies, such as, but not limited to, image acquisition devices or systems, software for image-acquisition, image processing, image-guided therapy, contrast kinetic modeling, or 3-D reconstruction and quantitative tools.

See full description in NIH Guide: PAR-06-293

Re-released at PAR-08-147 PAR-08-147